R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2021
Back to search
Official data from USPTO
IMGT IMAGE GUIDED THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
11/02/2021
Trademark type
Combined
Nice classes
5, 10, 42
Filing date
06/26/2020
Registration date
11/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/02/2021
Last transaction
11/02/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Gyeonggido, KR
Examiner
VAGHANI, MAYUR
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a bent molecule feature composed of a larger light blue orb with blue shading connected with two smaller light blue orbs with blue shading, next to the stylized wording of "IMGT" in blue, over the stylized wording of "IMage Guided Therapy" where the letters, "IM" are in blue, "age" are in light blue, "G" are in blue, "uided" are in light blue, "T" are in blue, and "herapy" are in light blue.
Holders and representatives
Holders
IMGT Co., Ltd.
Representatives
Yoon S. Ham HAUPTMAN HAM, LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Enzymes for medical purposes; Pharmaceutical preparations acting on the central nervous system; Antibiotic preparations; Chemotherapeutics; Veterinary vaccines; Vaccines; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of CNS disorders; Pharmaceutical preparations for the treatment of peripheral vascular or neurologic disease; Pharmaceutical preparations for the treatment of lesions; Pharmaceutical preparations for reliving pain; Pharmaceutical preparations for activating drug delivery; Nutraceuticals for use as a dietary supplement for promoting digestion; Anti-cancer preparations
Class 10
Medical apparatusmedical ultrasound apparatus; Medical apparatusultrasound diagnostic apparatus; Medical instruments for use in general surgery; Medical apparatus for treating cancer; Medical apparatus for treating cancer by using ultrasound; Medical apparatus for treating CNS disorders; Medical apparatus for treating CNS disorders by using ultrasound; Medical apparatus for treating peripheral vascular or neurologic disease; Medical apparatus for treating peripheral vascular or neurologic disease by using ultrasound; Medical apparatus for treating dermatological disease by using ultrasound; Medical apparatus for treating dermatological disease; Medical apparatus for treatment of lesions; Medical apparatus for treatment of lesions through hyperthermia caused by using ultrasound; Medical apparatus for relieving pain; Medical apparatus for relieving pain by using ultrasound; Medical apparatus for activating drug delivery; Medical apparatus for activating drug delivery by using ultrasound; Syringes for medical purposes and for injections; Medical apparatus for detecting cancer; Dental instrumentspicksburrsmirrorsprophy anglesoral irrigatorscrown and bridge removers; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Injection device for pharmaceuticals; Syringes for medical purposes; Syringes for injection of medical substances; Hypodermic syringes
Class 42
Drug discovery services; Biotechnology research; Biomedical research services; Laboratory research in the field of biology; Providing information on the subject of scientific research in the field of Biochemistry and biotechnology; Biological research; Bacteriological research; Pharmaceutical research and development; Research on the subject of pharmaceuticals; Clinical research in the field of medicines for detection and treatment of cancer; Conducting clinical trials for others in the field of medicines for detection and treatment of cancer; Medical research services; Scientific research for medical purposes in the field of cancer; Testing of pharmaceuticals; Testing of materials; Chemical research and analysis; Chemical research services
Publications
History of USPTO decisions and trademark events.
23 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2021
PUBO
PUBLISHED FOR OPPOSITION
08/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/07/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/22/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/22/2021
CNSL
SUSPENSION LETTER WRITTEN
03/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2021
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
10/02/2020
ALIE
ASSIGNED TO LIE
10/02/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/02/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/02/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
10/02/2020
DOCK
ASSIGNED TO EXAMINER
09/29/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2020
NWAP
NEW APPLICATION ENTERED
06/30/2020
Continuous trademark protection
Get notified about every new filing that threatens IMGT IMAGE GUIDED THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.